4-羟基三苯氧胺
4-羟基三苯氧胺 性质
| 熔点 | 105-107°C |
|---|---|
| 沸点 | 513.45°C (rough estimate) |
| 密度 | 1.1005 (rough estimate) |
| 折射率 | 1.6000 (estimate) |
| 储存条件 | 2-8°C |
| 溶解度 | 95%乙醇：20 mg/mL |
| 酸度系数(pKa) | 10.35±0.15(Predicted) |
| 形态 | 粉末 |
| 颜色 | 白色 |
| 稳定性 | 稳定的。存放干燥通风处。与强氧化剂不相容。 |
| InChI | InChI=1S/C26H29NO2/c1-4-25(20-8-6-5-7-9-20)26(21-10-14-23(28)15-11-21)22-12-16-24(17-13-22)29-19-18-27(2)3/h5-17,28H,4,18-19H2,1-3H3/b26-25- |
| InChIKey | TXUZVZSFRXZGTL-OCEACIFDSA-N |
| SMILES | C1(O)=CC=C(/C(/C2=CC=C(OCCN(C)C)C=C2)=C(/C2=CC=CC=C2)\CC)C=C1 |
| CAS 数据库 | 68047-06-3 |
4-羟基三苯氧胺 用途与合成方法
|
Estrogen receptor 3.3 nM (IC 50 ) |
CRISPR/Cas9
|
4-Hydroxytamoxifen (Monohydroxytamoxifen) is a selective oestrogen receptor antagonist, with an IC 50 of 3.3 nM for the [ 3 H]oestradiol binding to oestrogen receptor. 4-Hydroxytamoxifen (10, 100 nM) enables to inhibit the binding of [ 3 H]oestradiol to the human 8 S oestrogen receptor. 4-Hydroxytamoxifen activates intein-linked inactive Cas9, reduces off-target CRISPR-mediated gene editing. In human cells, conditionally active Cas9s modify target genomic sites with up to 25-fold higher specificity than wild-type Cas9.
4-Hydroxytamoxifen (0.2, 1 and 5 μg/day, p.o.) causes a dose-related decrease in uterine wet weight of immature rats. 4-Hydroxytamoxifen (6 μg/0.1 mL sesame oil/day, s.c.) effectively attenuates methamphetamine-induced nigrostriatal dopamine depletions in bothsexes of intact and gonadectomized C57BL/6 J mice. 4-Hydroxytamoxifen does not alter the dopamine content levels in the striatum.
安全信息
| 危险品标志 | Xn |
|---|---|
| 危险类别码 | 20/21/22-63 |
| 安全说明 | 22-23-36 |
| WGK Germany | 3 |
| RTECS号 | SL1210000 |
| 存储类别 | 6.1C - 可燃，急性毒性 类别3 毒性化合物或者引起慢性影响的化合物 |
| 危险性类别 | 急性毒性 类别4 经口 危害水生环境-急性危害 类别1 危害水生环境-长期危害 类别1 致癌性 类别1B 生殖毒性 类别1B |
4-羟基三苯氧胺 价格(试剂级)
| 更新日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
|---|---|---|---|---|---|
| 2026-09-15 | HY-16950R | 4-羟基三苯氧胺 | 68047-06-3 | 5 mg | 1800 |
| 2026-09-15 | HY-16950 | 4-羟基三苯氧胺 | 68047-06-3 | 1 mg | 320 |
